THE PHARMACOKINETICS OF VINCRISTINE IN MAN - REDUCED DRUG CLEARANCE ASSOCIATED WITH RAISED SERUM ALKALINE-PHOSPHATASE AND DOSE-LIMITED ELIMINATION

被引：91

作者：

VANDENBERG, HW

DESAI, ZR

WILSON, R

KENNEDY, G

BRIDGES, JM

SHANKS, RG

机构：

[1] QUEENS UNIV BELFAST,DEPT HAEMATOL,BELFAST BT9 7BL,ANTRIM,NORTH IRELAND

[2] QUEENS UNIV BELFAST,DEPT BIOCHEM,BELFAST BT9 7BL,ANTRIM,NORTH IRELAND

来源：

CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1982年 / 8卷 / 02期

关键词：

D O I：

10.1007/BF00255487

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：215 / 219

页数：5

共 11 条

[1] NEUROMYOPATHY OF VINCRISTINE IN MAN - CLINICAL, ELECTROPHYSIOLOGICAL AND PATHOLOGICAL STUDIES [J].

BRADLEY, WG ;

LASSMAN, LP ;

PEARCE, GW ;

WALTON, JN .

JOURNAL OF THE NEUROLOGICAL SCIENCES, 1970, 10 (02) :107-+

[2] CAN SEVERE VINCRISTINE NEUROTOXICITY BE PREVENTED [J].

DESAI, ZR ;

VANDENBERG, HW ;

BRIDGES, JM ;

SHANKS, RG .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 8 (02) :211-214

[3]

GIBALDI M, 1975, DRUGS PHARM SCI, V1, P53

[4]

GREGORY DH, 1978, GASTROENTEROLOGY, V74, P993

[5]

JACKSON DV, 1978, CLIN PHARMACOL THER, V24, P101

[6] COMPARATIVE PHARMACOKINETICS OF VINDESINE, VINCRISTINE AND VINBLASTINE IN PATIENTS WITH CANCER [J].

NELSON, RL ;

DYKE, RW ;

ROOT, MA .

CANCER TREATMENT REVIEWS, 1980, 7 :17-24

[7] VINCRISTINE TOXICITY UNRELATED TO DOSE [J].

OCALLAGHAN, MJ ;

EKERT, H .

ARCHIVES OF DISEASE IN CHILDHOOD, 1976, 51 (04) :289-292

[8]

OWELLEN RJ, 1975, CANCER RES, V35, P975

[9]

SHAW RICHARD K, 1964, CANCER CHEMOTHERAP REP, V42, P45

[10] RADIOIMMUNOASSAY OF VINBLASTINE AND VINCRISTINE [J].

TEALE, JD ;

CLOUGH, JM ;

MARKS, V .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 4 (02) :169-172

← 1 2 →